Should we be using activated protein C to treat severe sepsis?
作者信息
Eve R L, Duffy M R
机构信息
Anaesthesia and Intensive Care Medicine, Department of Intensive Care, Derriford Hospital, Plymouth, Devon, UK.
出版信息
Br J Hosp Med (Lond). 2009 Aug;70(8):484. doi: 10.12968/hmed.2009.70.8.43548.
Abstract
摘要
相似文献
1
Should we be using activated protein C to treat severe sepsis?我们应该使用活化蛋白C来治疗严重脓毒症吗？
Br J Hosp Med (Lond). 2009 Aug;70(8):484. doi: 10.12968/hmed.2009.70.8.43548.
2
3
Risks and benefits of activated protein C treatment for severe sepsis.活化蛋白C治疗严重脓毒症的风险与益处
N Engl J Med. 2002 Sep 26;347(13):1027-30. doi: 10.1056/NEJMsb020574.
4
[Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis].
Ned Tijdschr Geneeskd. 2006 Jun 3;150(22):1265-6; author reply 1266.
5
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.重新评估重组人活化蛋白C治疗脓毒症：开展新的随机对照试验的时候了。
Crit Care Med. 2005 Oct;33(10):2426-8. doi: 10.1097/01.ccm.0000183002.26587.ff.
6
Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated).重组人活化蛋白C的药理学、临床疗效及安全性
Pharmacotherapy. 2002 Dec;22(12 Pt 2):182S-195S. doi: 10.1592/phco.22.18.182s.33704.
7
Assessing the use of activated protein C in the treatment of severe sepsis.评估活化蛋白C在严重脓毒症治疗中的应用。
N Engl J Med. 2002 Sep 26;347(13):1030-4. doi: 10.1056/NEJMsb021512.
8
[Sepsis therapy -- how effective are the therapy strategies?].[脓毒症治疗——治疗策略的效果如何？]
Chirurg. 2008 Sep;79(9):877-8.
9
Drotrecogin alfa (activated) approved for treatment of severe sepsis.活化蛋白C已被批准用于治疗严重脓毒症。
J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):520-2. doi: 10.1331/108658002763316996.
10
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials.重组人活化蛋白C用于脓毒症治疗：试验结果不一致、作用机制不明以及安全性问题导致了标签限制和开展IV期试验的必要性。
Crit Care Med. 2003 Jan;31(1 Suppl):S94-6. doi: 10.1097/00003246-200301001-00013.
引用本文的文献
1
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.组织炎症和损伤中的蛋白 C 途径：致病作用和治疗意义。
Blood. 2010 Feb 11;115(6):1121-30. doi: 10.1182/blood-2009-09-201616. Epub 2009 Dec 17.
Zotero 插件